World Leaders in Genomics

The Medical Genomics Board is made up of world leaders in genomics with multidisciplinary expertise with scientists and qualified genomics professionals, including geneticists, molecular biochemists and clinical experts in pharmacogenomics, nutrigenomics and oncogenomics, prenatal, neonatal and pediatric rare diseases.

Our goal

The goal is to pursue the path of personalized therapeutic maps through the organization of a clear reporting system despite the great complexity of the data deriving from the whole genome sequencing in NGS. It is Dante’s intention to establish more of these regional Medical Genomics Boards around the world to bring genomics to the forefront of precision medicine in healthcare, taking into account the regional and cultural considerations of each area.

Bringing expertise on board

The members of the Board all come from medical and academia backgrounds, including doctors, pharmacists and biologists. These experts in Omic sciences were chosen to cover all therapeutic areas, from oncogenomics to pharmacogenomics.

  • Giuseppe Novelli

    Scientific Director - Scholar of multifactorial genetic diseases

  • Giovanni Pellacani

    Professor in dermatology at the Sapienza University of Rome

  • Laura di Renzo

    From the Tor Vergata Polyclinic in Rome where she deals with nutrigenetics and nutrigenomics

  • Sergio Bernardini

    Professor in clinical biochemistry and molecular biology

  • Antonio Novelli

    Who deals with genomics in prenatal diagnosis at the Bambino Gesù Children's Hospital in Rome

  • Salvatore Minisola

    Professor in Internal Medicine at the Sapienza University of Rome

  • Camilla Nero

    Expert on oncogenomics from the Catholic University of Rome

1 of 7